Sio Capital Management, LLC Syros Pharmaceuticals, Inc. Transaction History

Sio Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.69 - $1.21 $623,005 - $1.09 Million	-902,907 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.02 - $3.8 $2,274 - $8,474	2,230 Added 0.25%	902,907 $1.07 Million
Q3 2021 Nov 15, 2021	BUY	$4.08 - $5.66 $410,762 - $569,831	100,677 Added 12.58%	900,677 $4.03 Million
Q2 2021 Aug 16, 2021	BUY	$5.01 - $7.48 $4.01 Million - $5.98 Million	800,000 New	800,000 $4.36 Million
Q4 2020 Feb 16, 2021	SELL	$6.66 - $14.66 $1.11 Million - $2.44 Million	-166,780 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$8.69 - $14.47 $922,200 - $1.54 Million	-106,122 Reduced 38.89%	166,780 $1.47 Million
Q2 2020 Aug 14, 2020	SELL	$5.21 - $11.03 $1.02 Million - $2.16 Million	-195,630 Reduced 41.75%	272,902 $2.91 Million
Q1 2020 May 15, 2020	BUY	$4.46 - $9.2 $89,200 - $184,000	20,000 Added 4.46%	468,532 $2.78 Million
Q4 2019 Feb 14, 2020	BUY	$4.52 - $10.1 $2.03 Million - $4.53 Million	448,532 New	448,532 $3.1 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $4.25M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.